loadpatents
name:-0.59996914863586
name:-0.50227403640747
name:-0.073200941085815
Yacoby-Zeevi; Oron Patent Filings

Yacoby-Zeevi; Oron

Patent Applications and Registrations

Patent applications and USPTO patent grants for Yacoby-Zeevi; Oron.The latest application filed is for "method for treatment of parkinson's disease".

Company Profile
9.23.49
  • Yacoby-Zeevi; Oron - Moshav Bitsaron IL
  • Yacoby-Zeevi; Oron - Bitsaron N/A IL
  • Yacoby-Zeevi; Oron - Tel Aviv-Jaffa IL
  • Yacoby-Zeevi; Oron - Tel Aviv-Yafo IL
  • Yacoby-Zeevi; Oron - Moshav Bizaron IL
  • Yacoby-Zeevi, Oron - Moshav Bizaron 204 IL
  • Yacoby-Zeevi, Oron - Meitar IL
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Method For Treatment Of Parkinson's Disease
App 20210093560 - Yacoby-Zeevi; Oron
2021-04-01
Continuous Administration of Dopa Decarboxylase Inhibitors and Compositions for Same
App 20210077442 - Yacoby-Zeevi; Oron ;   et al.
2021-03-18
Dopa Decarboxylase Inhibitor Compositions
App 20210038505 - Yacoby-Zeevi; Oron
2021-02-11
Dopa Decarboxylase Inhibitor Compositions
App 20210000777 - Yacoby-Zeevi; Oron
2021-01-07
Continuous Administration of L-Dopa, Dopa Decarboxylase Inhibitors, Catechol-O-Methyl Transferase Inhibitors and Compositions for Same
App 20200397730 - Yacoby-Zeevi; Oron ;   et al.
2020-12-24
DOPA decarboxylase inhibitor compositions
Grant 10,813,902 - Yacoby-Zeevi October 27, 2
2020-10-27
Dopa decarboxylase inhibitor compositions
Grant 10,624,839 - Yacoby-Zeevi
2020-04-21
Dopa Decarboxylase Inhibitor Compositions
App 20200046665 - Yacoby-Zeevi; Oron
2020-02-13
Compositions comprising apomorphine and organic acids and uses thereof
Grant 10,525,134 - Yacoby-Zeevi , et al. J
2020-01-07
Dopa Decarboxylase Inhibitor Compositions
App 20190151233 - Yacoby-Zeevi; Oron
2019-05-23
Continuous Administration of Dopa Decarboxylase Inhibitors and Compositions for Same
App 20190125708 - Yacoby-Zeevi; Oron ;   et al.
2019-05-02
DOPA decarboxylase inhibitor compositions
Grant 10,258,585 - Yacoby-Zeevi
2019-04-16
Compositions Comprising Apomorphine And Organic Acids And Uses Thereof
App 20180303939 - Yacoby-Zeevi; Oron ;   et al.
2018-10-25
Dopa decarboxylase inhibitor compositions
Grant 10,022,320 - Yacoby-Zeevi July 17, 2
2018-07-17
Compositions comprising apomorphine and organic acids and uses thereof
Grant 9,999,674 - Yacoby-Zeevi , et al. June 19, 2
2018-06-19
Continuous administration of dopa decarboxylase inhibitors and compositions for same
Grant 9,993,451 - Yacoby-Zeevi , et al. June 12, 2
2018-06-12
Opipramol Patch
App 20180140610 - YACOBY-ZEEVI; Oron ;   et al.
2018-05-24
Crystal Forms Of Apomorphine And Uses Thereof
App 20170368052 - Yacoby-Zeevi; Oron ;   et al.
2017-12-28
Pharmaceutical Compositions Comprising Levodopa Amide And Uses Thereof
App 20170296491 - Yacoby-Zeevi; Oron ;   et al.
2017-10-19
Continuous Administration of Levodopa and/or Dopa Decarboxylase Inhibitors and Compositions for Same
App 20170196828 - Yacoby-Zeevi; Oron ;   et al.
2017-07-13
Compositions For Transdermal Delivery Of Active Agents
App 20170157076 - Yacoby-Zeevi; Oron ;   et al.
2017-06-08
Continuous Administration Of L-dopa, Dopa Decarboxylase Inhibitors, Catechol-o-methyl Transferase Inhibitors And Compositions For Same
App 20170157077 - Yacoby-Zeevi; Oron ;   et al.
2017-06-08
Dopa Decarboxylase Inhibitor Compositions
App 20170157079 - Yacoby-Zeevi; Oron
2017-06-08
Continuous administration of L-dopa, dopa decarboxylase inhibitors, catechol-O-methyl transferase inhibitors and compositions for same
Grant 9,421,267 - Yacoby-Zeevi , et al. August 23, 2
2016-08-23
Compositions for transdermal delivery of active agents
Grant 9,415,108 - Yacoby-Zeevi , et al. August 16, 2
2016-08-16
Compositions comprising apomorphine and organic acids and uses thereof
Grant 9,381,249 - Yacoby-Zeevi , et al. July 5, 2
2016-07-05
Continuous Administration of Dopa Decarboxylase Inhibitors and Compositions for Same
App 20160151317 - Yacoby-Zeevi; Oron ;   et al.
2016-06-02
Compositions Comprising Apomorphine And Organic Acids And Uses Thereof
App 20160067339 - Yacoby-Zeevi; Oron ;   et al.
2016-03-10
Method For Treatment Of Parkinson's Disease
App 20160022573 - Yacoby-Zeevi; Oron
2016-01-28
Dopa Decarboxylase Inhibitor Compositions
App 20150352212 - Yacoby-Zeevi; Oron
2015-12-10
Continuous administration of dopa decarboxylase inhibitors and compositions for same
Grant 9,101,663 - Yacoby-Zeevi , et al. August 11, 2
2015-08-11
Compositions Comprising Apomorphine And Organic Acids And Uses Thereof
App 20150182523 - Yacoby-Zeevi; Oron ;   et al.
2015-07-02
Continuous administration of L-dopa, dopa decarboxylase inhibitors, catechol-O-methyl transferase inhibitors and compositions for same
Grant 9,040,578 - Yacoby-Zeevi , et al. May 26, 2
2015-05-26
Continuous administration of dopa decarboxylase inhibitors and compositions for same
Grant 9,040,589 - Yacoby-Zeevi , et al. May 26, 2
2015-05-26
Continuous administration of L-dopa, dopa decarboxylase inhibitors, catechol-O-methyl transferase inhibitors and compositions for same
Grant 9,040,577 - Yacoby-Zeevi , et al. May 26, 2
2015-05-26
Continuous administration of dopa decarboxylase inhibitors and compositions for same
Grant 9,040,590 - Yacoby-Zeevi , et al. May 26, 2
2015-05-26
Continuous Administration Of L-dopa, Dopa Decarboxylase Inhibitors, Catechol-o-methyl Transferase Inhibitors And Compositions For Same
App 20140249228 - Yacoby-Zeevi; Oron ;   et al.
2014-09-04
Continuous Administration Of L-dopa, Dopa Decarboxylase Inhibitors, Catechol-o-methyl Transferase Inhibitors And Compositions For Same
App 20140249229 - Yacoby-Zeevi; Oron ;   et al.
2014-09-04
Continuous Administration of Dopa Decarboxylase Inhibitors and Compositions for Same
App 20140249231 - Yacoby-Zeevi; Oron ;   et al.
2014-09-04
Continuous Administration of Dopa Decarboxylase Inhibitors and Compositions for Same
App 20140249230 - Yacoby-Zeevi; Oron ;   et al.
2014-09-04
Continuous Administration of L-Dopa, Dopa Decarboxylase Inhibitors, Catechol-O-Methyl Transferase Inhibitors and Compositions for Same
App 20140051755 - Yacoby-Zeevi; Oron ;   et al.
2014-02-20
Compositions for Transdermal Delivery of Active Agents
App 20130338143 - Yacoby-Zeevi; Oron ;   et al.
2013-12-19
Continuous Administration of Levodopa and/or Dopa Decarboxylase Inhibitors and Compositions for Same
App 20130253056 - Nemas; Mara ;   et al.
2013-09-26
Continuous administration of dopa decarboxylase inhibitors and compositions for same
Grant 8,193,243 - Yacoby-Zeevi , et al. June 5, 2
2012-06-05
Continuous Administration of Dopa Decarboxylase Inhibitors and Compositions for Same
App 20110269833 - Yacoby-Zeevi; Oron ;   et al.
2011-11-03
Continuous administration of dopa decarboxylase inhibitors and compositions for same
Grant 7,863,336 - Yacoby-Zeevi , et al. January 4, 2
2011-01-04
Continuous Administration of Dopa Decarboxylase Inhibitors and Compositions for Same
App 20100298429 - Yacoby-Zeevi; Oron ;   et al.
2010-11-25
Continuous Administration of Dopa Decarboxylase Inhibitors and Compositions for Same
App 20100298428 - Yacoby-Zeevi; Oron ;   et al.
2010-11-25
Heparanase activity neutralizing anti-heparanase monclonal antibody and other anti-heparanase antibodies
App 20060269552 - Yacoby-Zeevi; Oron ;   et al.
2006-11-30
Methods of and pharmaceutical compositions for improving implantation of embryos
App 20060008892 - Yacoby-Zeevi; Oron
2006-01-12
Therapeutic and cosmetic uses of heparanases
App 20050260187 - Ilan, Neta ;   et al.
2005-11-24
Heparanase activity neutralizing anti-heparanase monoclonal antibody and other anti-heparanase antibodies
App 20040213789 - Yacoby-Zeevi, Oron ;   et al.
2004-10-28
Introducing a biological material into a patient
App 20040175371 - Yacoby-Zeevi, Oron
2004-09-09
Heparanase activity neutralizing anti-heparanase monoclonal antibody and other anti-heparanase antibodies
App 20040170631 - Yacoby-Zeevi, Oron ;   et al.
2004-09-02
Therapeutic and cosmetic uses of heparanases
App 20040146497 - Ilan, Neta ;   et al.
2004-07-29
Methods and kits utilizing heparanase as a diagnostic marker for haemostatic disorders
App 20040132123 - Yacoby-Zeevi, Oron
2004-07-08
Use of ecm degrading enzymes for the improvement of cell transplantation
App 20040033218 - Yacoby-Zeevi, Oron
2004-02-19
Therapeutic and cosmetic uses of heparanases
App 20030161823 - Ilan, Neta ;   et al.
2003-08-28
Genetically modified cells and methods for expressing recombinant heparanase and methods of purifying same
App 20030068806 - Ayal-Hershkovitz, Maty ;   et al.
2003-04-10
Method of inducing bone formation
App 20030031660 - Yacoby-Zeevi, Oron
2003-02-13
Genetically modified cells and methods for expressing recombinant heparanase and methods of purifying same
Grant 6,475,763 - Ayal-Hershkovitz , et al. November 5, 2
2002-11-05
Methods of and pharmaceutical compositions for improving implantation of embryos
App 20020088019 - Yacoby-Zeevi, Oron
2002-07-04
Therapeutic and cosmetic uses of heparanases
App 20020068054 - Ilan, Neta ;   et al.
2002-06-06
Compositions Including Glycosaminoglycans Degrading Enzymes And Use Of Same Against Surface Protected Bacteria
App 20020064858 - YACOBY-ZEEVI, ORON
2002-05-30
Genetically modified cells and methods for expressing recombinant heparanase and methods of purifying same
Grant 6,348,344 - Ayal-Hershkovitz , et al. February 19, 2
2002-02-19
Introducing A Biological Material Into A Patient
App 20010006630 - YACOBY-ZEEVI, ORON
2001-07-05
Use of glycosaminoglycans degrading enzymes for management of airway associated diseases
Grant 6,153,187 - Yacoby-Zeevi November 28, 2
2000-11-28

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed